tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AARD Stock Latest News

Aardvark Therapeutics reports inducement grants under Nasdaq listing rule
The FlyAardvark Therapeutics reports inducement grants under Nasdaq listing rule
9d ago
AARD
Aardvark Therapeutics Updates Corporate Presentation on Strategy
PremiumCompany Announcements
Aardvark Therapeutics Updates Corporate Presentation on Strategy
10d ago
8K
AARD
Aardvark Therapeutics price target lowered to $25 from $26 at BofA
PremiumThe Fly
Aardvark Therapeutics price target lowered to $25 from $26 at BofA
16d ago
AARD
Aardvark Therapeutics Advances Clinical Trials and Financials
PremiumCompany Announcements
Aardvark Therapeutics Advances Clinical Trials and Financials
18d ago
AARD
Aardvark Therapeutics price target lowered to $19 from $20 at RBC Capital
PremiumThe Fly
Aardvark Therapeutics price target lowered to $19 from $20 at RBC Capital
1M ago
AARD
Aardvark Therapeutics reports Q2 EPS (66c), consensus (60c)
PremiumThe FlyAardvark Therapeutics reports Q2 EPS (66c), consensus (60c)
1M ago
AARD
Buy Rating for Aardvark Therapeutics, Inc. Driven by Promising ARD-201 Obesity Treatment Potential
Premium
Ratings
Buy Rating for Aardvark Therapeutics, Inc. Driven by Promising ARD-201 Obesity Treatment Potential
1M ago
AARD
Aardvark Therapeutics Reveals Promising Preclinical Data for ARD-201
Premium
Company Announcements
Aardvark Therapeutics Reveals Promising Preclinical Data for ARD-201
1M ago
8K
AARD
Aardvark Therapeutics announces preclinical data on ARD-201
PremiumThe Fly
Aardvark Therapeutics announces preclinical data on ARD-201
1M ago
AARD
Aardvark Therapeutics announces inducement grants under Nasdaq listing rule
PremiumThe Fly
Aardvark Therapeutics announces inducement grants under Nasdaq listing rule
2M ago
AARD
Aardvark Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Aardvark Therapeutics initiated with a Buy at H.C. Wainwright
3M ago
AARD
Aardvark Therapeutics participates in 2025 United in Hope Conference
PremiumThe Fly
Aardvark Therapeutics participates in 2025 United in Hope Conference
3M ago
AARD
Aardvark Therapeutics appoints Timothy Kieffer as CSO, Danny Villeneuve as CCO
PremiumThe FlyAardvark Therapeutics appoints Timothy Kieffer as CSO, Danny Villeneuve as CCO
4M ago
AARD
Aardvark Therapeutics Inc trading resumes
Premium
The Fly
Aardvark Therapeutics Inc trading resumes
4M ago
AARD
Aardvark Therapeutics Inc trading halted, volatility trading pause
Premium
The Fly
Aardvark Therapeutics Inc trading halted, volatility trading pause
4M ago
AARD
Promising Future for Aardvark Therapeutics: Buy Rating Backed by Strong Pipeline and Financial Health
PremiumRatings
Promising Future for Aardvark Therapeutics: Buy Rating Backed by Strong Pipeline and Financial Health
5M ago
AARD
Positive Outlook for Aardvark Therapeutics Amid Favorable Regulatory and Market Conditions
PremiumRatings
Positive Outlook for Aardvark Therapeutics Amid Favorable Regulatory and Market Conditions
6M ago
AARD
Aardvark Therapeutics price target raised to $26 from $22 at BofA
PremiumThe Fly
Aardvark Therapeutics price target raised to $26 from $22 at BofA
6M ago
AARD
SLNO
Aardvark Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Aardvark Therapeutics initiated with an Overweight at Cantor Fitzgerald
6M ago
AARD
Aardvark Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyAardvark Therapeutics initiated with an Overweight at Cantor Fitzgerald
6M ago
AARD
Aardvark Therapeutics initiated with an Outperform at RBC Capital
Premium
The Fly
Aardvark Therapeutics initiated with an Outperform at RBC Capital
6M ago
AARD
Aardvark Therapeutics initiated with a Buy at BofA
Premium
The Fly
Aardvark Therapeutics initiated with a Buy at BofA
6M ago
AARD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >